Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells
- 1 May 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 296 (5), H1675-H1682
- https://doi.org/10.1152/ajpheart.00665.2008
Abstract
Cell therapy with endothelial progenitor cells (EPCs) is an emerging therapeutic option to promote angiogenesis or endothelial repair. Although the release of angiogenic paracrine factors is known to contribute to their therapeutic effect, little is known about their release of proinflammatory factors and expression of proinflammatory adhesion molecules. “Early” EPCs and “late” EPCs were isolated from human peripheral blood and their release of chemokines and thromboinflammatory mediators as well as their expression of the proinflammatory adhesion molecules was assessed at baseline and with stimulation. The effect of simvastatin on monocyte chemoattractant protein-1 (MCP-1) secretion by late EPCs from patients with vascular disease was also evaluated. All groups of EPCs released chemokines and thromboinflammatory mediators. Early EPCs primarily released thromboinflammatory mediators such as tissue factor (0.5 ± 0.1 ng/million cells, P < 0.05), whereas adult late EPCs primarily released chemokines such as MCP-1 (287 ± 98 ng/million cells, P < 0.05). Stimulation with tumor necrosis factor (TNF)-α augmented the expression of proinflammatory adhesion molecules and paracrine factors by all EPC subtypes. The release of MCP-1 by late EPCs was markedly reduced by simvastatin treatment of the cells. All EPC subtypes expressed proinflammatory paracrine factors and adhesion molecules involved in atherosclerosis. Future clinical studies should therefore not only assess the efficacy of EPCs but also monitor inflammatory activation following EPC transplantation in patients. Pharmacological modulation of EPCs before and after transplantation may represent a novel approach to improve their safety.Keywords
This publication has 34 references indexed in Scilit:
- Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor‐α via the p38 mitogen‐activated protein kinase pathwayThe FASEB Journal, 2009
- An Inconvenient TruthCirculation Research, 2008
- Strikingly Different Angiogenic Properties of Endothelial Progenitor Cell SubpopulationsJournal of the American College of Cardiology, 2008
- Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heartThe Journal of Experimental Medicine, 2007
- Potential risks of bone marrow cell transplantation into infarcted heartsBlood, 2007
- Immune Cells Mimic the Morphology of Endothelial Progenitor Colonies In VitroThe International Journal of Cell Cloning, 2007
- Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principalsBlood, 2006
- Endothelial Progenitors: A New Tower of Babel?Journal of the American College of Cardiology, 2006
- The Number of Endothelial Progenitor Cell Colonies in the Blood Is Increased in Patients With Angiographically Significant Coronary Artery DiseaseJournal of the American College of Cardiology, 2006
- Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes MellitusJournal of the American College of Cardiology, 2005